Compare CFLT & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CFLT | TECH |
|---|---|---|
| Founded | 2014 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.7B | 9.5B |
| IPO Year | 2021 | 1989 |
| Metric | CFLT | TECH |
|---|---|---|
| Price | $30.09 | $58.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 33 | 14 |
| Target Price | $30.21 | ★ $71.23 |
| AVG Volume (30 Days) | ★ 17.1M | 1.7M |
| Earning Date | 10-27-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | $1,113,149,000.00 | ★ $1,216,732,000.00 |
| Revenue This Year | $22.76 | $2.33 |
| Revenue Next Year | $16.57 | $7.05 |
| P/E Ratio | ★ N/A | $120.22 |
| Revenue Growth | ★ 21.57 | 3.85 |
| 52 Week Low | $15.64 | $46.01 |
| 52 Week High | $37.90 | $79.28 |
| Indicator | CFLT | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 78.69 | 41.76 |
| Support Level | $22.91 | $58.75 |
| Resistance Level | $30.23 | $61.20 |
| Average True Range (ATR) | 0.54 | 2.02 |
| MACD | 0.88 | -0.49 |
| Stochastic Oscillator | 98.41 | 2.94 |
Confluent Inc provides a data streaming platform that enables customers to connect their applications, systems, and data layers and can be deployed as a fully managed cloud-native software-as-a-service (SaaS) offering. Its products include Confluent Cloud, a self-managed software offering, Confluent Platform, a managed service offering where the raw data resides inside a customer's cloud environment, and WarpStream, among others. Confluent also offers professional services and education services. The company generates revenue from the sale of subscriptions and services. Geographically, it generates a majority of its revenue from its business in the United States and the rest from International markets.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.